186 related articles for article (PubMed ID: 30828566)
1. Chemoradiotherapy-Induced CD4
Chen X; Zhang W; Qian D; Guan Y; Wang Y; Zhang H; Er P; Yan C; Li Y; Ren X; Pang Q; Wang P
Front Oncol; 2019; 9():73. PubMed ID: 30828566
[No Abstract] [Full Text] [Related]
2. Effect of chemoradiotherapy on the proportion of circulating lymphocyte subsets in patients with limited-stage small cell lung cancer.
Chen Y; Jin Y; Hu X; Chen M
Cancer Immunol Immunother; 2021 Oct; 70(10):2867-2876. PubMed ID: 33674986
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of EGF and uPAR for chemoradiotherapy response and survival in patients with esophageal squamous cell carcinoma.
Chen X; Wei H; Qian D; Wang Y; Guan Y; Er P; Song Y; Liu N; Wang J; Zhao L; Yuan Z; Wang P; Pang Q; Zhang W
Ann Transl Med; 2020 Sep; 8(18):1152. PubMed ID: 33241001
[TBL] [Abstract][Full Text] [Related]
4. Abnormal variation and prognostic significance of circulating immune cells in patients with nasopharyngeal carcinoma treated with chemoradiotherapy: a prospective cohort study.
Huang C; Ding J; Huang C; Yu L; Chitapanarux I; Mejia MBA; Fei Z; Chen C
Transl Cancer Res; 2023 Dec; 12(12):3718-3727. PubMed ID: 38192995
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy.
Zhang T; Guo Z; Chen X; Dong J; Jiang H; Tang P; Wang P; Qian D; Zhang W; Pang Q
Radiat Oncol; 2022 Aug; 17(1):148. PubMed ID: 35999608
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and predictive significance of circulating biomarkers in patients with advanced upper gastrointestinal cancer undergoing systemic chemotherapy.
Li N; Gao L; Ge Y; Zhao L; Bai C; Wang Y
Front Oncol; 2023; 13():1195848. PubMed ID: 37346066
[TBL] [Abstract][Full Text] [Related]
7. Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma.
Zhang W; Yan C; Gao X; Li X; Cao F; Zhao G; Zhao J; Er P; Zhang T; Chen X; Wang Y; Jiang Y; Wang Q; Zhang B; Qian D; Wang J; Zhou D; Ren X; Yu Z; Zhao L; Yuan Z; Wang P; Pang Q
Oncologist; 2021 Jul; 26(7):e1110-e1124. PubMed ID: 33893689
[TBL] [Abstract][Full Text] [Related]
8. Chemoradiotherapy Versus Chemotherapy Alone for Advanced Esophageal Squamous Cell Carcinoma: The Role of Definitive Radiotherapy for Primary Tumor in the Metastatic Setting.
Li LQ; Fu QG; Zhao WD; Wang YD; Meng WW; Su TS
Front Oncol; 2022; 12():824206. PubMed ID: 35433478
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of anti-PD-1 antibody plus chemoradiotherapy in locally advanced esophageal squamous cancer.
Ma J; Yao N; Lu J; Qu W; Cui L; Yuan S; Li N; Tong S; Qin Z; Yao Y
Front Oncol; 2023; 13():1005856. PubMed ID: 36845696
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of PD-L1 expression on tumor cells combined with CD8+ TIL density in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
Gennen K; Käsmann L; Taugner J; Eze C; Karin M; Roengvoraphoj O; Neumann J; Tufman A; Orth M; Reu S; Belka C; Manapov F
Radiat Oncol; 2020 Jan; 15(1):5. PubMed ID: 31898519
[TBL] [Abstract][Full Text] [Related]
11. Pre- versus postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
Hsu PK; Chen HS; Liu CC; Huang CS; Hsieh CC; Hsu HS; Wu SC
J Thorac Cardiovasc Surg; 2017 Aug; 154(2):732-740.e2. PubMed ID: 28457536
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of peripheral CD8+CD28+ and CD8+CD28- T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy.
Liu C; Jing W; An N; Li A; Yan W; Zhu H; Yu J
J Transl Med; 2019 Oct; 17(1):344. PubMed ID: 31623615
[TBL] [Abstract][Full Text] [Related]
13. Postchemoradiotherapy Pathologic Stage Classified by the American Joint Committee on the Cancer Staging System Predicts Prognosis of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma.
Guo JC; Huang TC; Lin CC; Hsieh MS; Chang CH; Huang PM; Lee JM; Hsu FM; Chia-Hsien Cheng J; Wang HP; Yeh KH; Cheng AL; Hsu CH
J Thorac Oncol; 2015 Oct; 10(10):1481-9. PubMed ID: 26313683
[TBL] [Abstract][Full Text] [Related]
14. Comparative Outcomes of Induction Chemotherapy Followed By Definitive Chemoradiotherapy versus Chemoradiotherapy Alone In Esophageal Squamous Cell Carcinoma.
Luo LL; Xi M; Yang YD; Li QQ; Zhao L; Zhang P; Liu SL; Liu MZ
J Cancer; 2017; 8(17):3441-3447. PubMed ID: 29151927
[No Abstract] [Full Text] [Related]
15. Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer.
Kelly JR; Park HS; An Y; Yarbrough WG; Contessa JN; Decker R; Mehra S; Judson BL; Burtness B; Husain Z
Oral Oncol; 2018 Apr; 79():64-70. PubMed ID: 29598952
[TBL] [Abstract][Full Text] [Related]
16. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic debulking resection with additive chemoradiotherapy: Optimal management of advanced inoperable esophageal squamous cell carcinoma.
Ren LH; Zhu Y; Chen R; Shrestha Sachin M; Lu Q; Xie WH; Lu T; Wei XY; Shi RH
World J Gastrointest Oncol; 2022 Sep; 14(9):1758-1770. PubMed ID: 36187386
[TBL] [Abstract][Full Text] [Related]
18. The lymphocyte-monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy.
Liu X; Li M; Zhao F; Zhu Y; Luo Y; Kong L; Zhu H; Zhang Y; Shi F; Yu J
Onco Targets Ther; 2017; 10():871-877. PubMed ID: 28243122
[TBL] [Abstract][Full Text] [Related]
19. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Yap WK; Chang YC; Hsieh CH; Chao YK; Chen CC; Shih MC; Hung TM
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):689-698. PubMed ID: 29188300
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of Circulating Lymphocyte Subsets Before Treatment in Patients with Nasopharyngeal Carcinoma.
Shen DS; Yan C; Liang Y; Chen KH; Zhu XD
Cancer Manag Res; 2021; 13():8109-8120. PubMed ID: 34737639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]